Loading...

Home
ETF
LBRX

LBRX

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

LBRX News

Helus Pharma Advances Mental Health Drug Development

Feb 27 2026Newsfilter

Helus Pharma Advances Psychedelic Drug Clinical Trials

Feb 27 2026PRnewswire

LB Pharmaceuticals Grants Equity Award to New General Counsel

Feb 10 2026Newsfilter

LB Pharmaceuticals Plans $100M Private Placement

Feb 05 2026seekingalpha

Aktis Oncology Files for IPO in the U.S. Targeting $346 Million in Funding

Dec 19 2025Newsfilter

LB Pharmaceuticals Appoints New CCO and Grants 195,000 Stock Options

Dec 10 2025Globenewswire

LB Pharmaceuticals Appoints New CCO and Grants 195,000 Stock Options

Dec 10 2025Newsfilter

LB Pharmaceuticals Included in Russell 2000 and 3000 Indices, Boosting Investor Awareness

Dec 09 2025Newsfilter

Major Stocks on the Rise Monday: Jazz Pharmaceuticals, Sigma Lithium, Zymeworks, and More

Nov 17 2025Benzinga